Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.2%
    Check dated 2025-10-12T14:26:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T09:53:07.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated the condition name capitalization and bumped the revision to v3.1.0; older lowercase naming and v3.0.2 were removed to align with the new version.
    Difference
    0.1%
    Check dated 2025-09-28T03:09:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updated Revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. Overall, changes are minor with no impact on core content, pricing, stock, or time slots.
    Difference
    0.3%
    Check dated 2025-09-13T16:55:06.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T14:31:42.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations, as well as new medical topics related to obesity and genetic disorders. The revision number has also been updated to reflect the latest version.
    Difference
    3%
    Check dated 2025-08-30T11:19:55.000Z thumbnail image

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.